Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.050 (-2.04%)
At close: Apr 28, 2026, 4:00 PM EDT
2.406
+0.006 (0.23%)
After-hours: Apr 28, 2026, 6:10 PM EDT
CNTB Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CNTB stock have an average target of 8.67, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 261.25% from the current stock price of 2.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CNTB stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.67% | Apr 1, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.67% | Mar 31, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +275.00% | Dec 1, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.67% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +316.67% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
n/a
from 64.00K
Revenue Next Year
97.52M
EPS This Year
-4.18
from -1.00
EPS Next Year
-3.64
from -4.18
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 301.2M | ||||||
| Avg | n/a | 97.5M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.89 | -0.79 | |
| Avg | -4.18 | -3.64 | |
| Low | -7.18 | -6.76 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.